| RS2525806571 |
ASH1L
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 52 |
| RS2525817360 |
DARS2
|
Health Risk |
Pathogenic |
Leukoencephalopathy with brain stem and spinal cord involvement-high lactate syndrome, Leukoencephalopathy with brain stem and spinal cord involvement-high lactate syndrome |
| RS2525817489 |
DARS2
|
Health Risk |
Pathogenic |
Leukoencephalopathy with brain stem and spinal cord involvement-high lactate syndrome, Leukoencephalopathy with brain stem and spinal cord involvement-high lactate syndrome |
| RS2525834257 |
ATP1A1
|
Health Risk |
Likely pathogenic |
Hypomagnesemia, seizures |
| RS2525836270 |
TBX19
|
Health Risk |
Likely pathogenic |
Congenital isolated adrenocorticotropic hormone deficiency, Congenital isolated adrenocorticotropic hormone deficiency |
| RS2525836300 |
TBX19
|
Health Risk |
Likely pathogenic |
Congenital isolated adrenocorticotropic hormone deficiency, Congenital isolated adrenocorticotropic hormone deficiency |
| RS2525846742 |
DARS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Leukoencephalopathy with brain stem and spinal cord involvement-high lactate syndrome, Leukoencephalopathy with brain stem and spinal cord involvement-high lactate syndrome |
| RS2525849428 |
DARS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS2525861491 |
ATP1A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-tooth disease, axonal |
| RS2525868703 |
DARS2
|
Health Risk |
Pathogenic |
— |
| RS2525873559 |
ARID1A
|
Health Risk |
Pathogenic |
Malignant tumor of urinary bladder, Malignant tumor of urinary bladder |
| RS2525878459 |
DARS2
|
Health Risk |
Likely pathogenic |
— |
| RS2525878524 |
DARS2
|
Health Risk |
Pathogenic |
— |
| RS2525888488 |
LAMC2
|
Health Risk |
Likely pathogenic |
— |
| RS2525903731 |
GORAB
|
Health Risk |
Pathogenic |
— |
| RS2525903868 |
GORAB
|
Health Risk |
Pathogenic |
— |
| RS2525904182 |
GORAB
|
Health Risk |
Pathogenic |
— |
| RS2525929426 |
GORAB
|
Health Risk |
Pathogenic |
— |
| RS2525929880 |
GORAB
|
Health Risk |
Likely pathogenic |
Geroderma osteodysplastica, Geroderma osteodysplastica |
| RS2525938436 |
ANO6
|
Health Risk |
Pathogenic |
— |
| RS2525938825 |
DARS2
|
Health Risk |
Likely pathogenic |
Leukoencephalopathy with brain stem and spinal cord involvement-high lactate syndrome, Leukoencephalopathy with brain stem and spinal cord involvement-high lactate syndrome |
| RS2525941193 |
GORAB
|
Health Risk |
Pathogenic |
— |
| RS2525948184 |
GORAB
|
Health Risk |
Pathogenic |
— |
| RS2525948734 |
GORAB
|
Health Risk |
Pathogenic |
— |
| RS2525968808 |
DMD
|
Health Risk |
Pathogenic/Likely pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2525970728 |
GORAB
|
Health Risk |
Pathogenic |
— |
| RS2525976456 |
LAMC2
|
Health Risk |
Likely pathogenic |
Junctional epidermolysis bullosa gravis of Herlitz, Junctional epidermolysis bullosa gravis of Herlitz |
| RS2525976672 |
LAMC2
|
Health Risk |
Likely pathogenic |
Junctional epidermolysis bullosa gravis of Herlitz, Junctional epidermolysis bullosa gravis of Herlitz |
| RS2525977235 |
LAMC2
|
Health Risk |
Likely pathogenic |
Junctional epidermolysis bullosa gravis of Herlitz, Junctional epidermolysis bullosa gravis of Herlitz |
| RS2525977277 |
DMD
|
Health Risk |
Likely pathogenic |
— |
| RS2526006147 |
LAMC2
|
Health Risk |
Likely pathogenic |
— |
| RS2526018764 |
CASQ2
|
Health Risk |
Pathogenic |
Catecholaminergic polymorphic ventricular tachycardia 2, Catecholaminergic polymorphic ventricular tachycardia 1 |
| RS2526020363 |
LAMC2
|
Health Risk |
Pathogenic |
— |
| RS2526020778 |
LAMC2
|
Health Risk |
Pathogenic |
— |
| RS2526031776 |
CASQ2
|
Health Risk |
Likely pathogenic |
Catecholaminergic polymorphic ventricular tachycardia 1, Cardiovascular phenotype |
| RS2526031953 |
CASQ2
|
Health Risk |
Likely pathogenic |
Catecholaminergic polymorphic ventricular tachycardia 2, Catecholaminergic polymorphic ventricular tachycardia 2 |
| RS2526032198 |
LAMC2
|
Health Risk |
Pathogenic |
— |
| RS2526032244 |
CASQ2
|
Health Risk |
Pathogenic |
Catecholaminergic polymorphic ventricular tachycardia 1, Catecholaminergic polymorphic ventricular tachycardia 1 |
| RS2526035615 |
TPM3
|
Health Risk |
Likely pathogenic |
Congenital myopathy with fiber type disproportion, Congenital myopathy with fiber type disproportion |
| RS2526037706 |
LAMC2
|
Health Risk |
Likely pathogenic |
Junctional epidermolysis bullosa gravis of Herlitz, Junctional epidermolysis bullosa gravis of Herlitz |
| RS2526037804 |
LAMC2
|
Health Risk |
Pathogenic |
— |
| RS2526038482 |
TPM3
|
Health Risk |
Pathogenic |
Congenital myopathy 4B, autosomal recessive |
| RS2526038543 |
TPM3
|
Health Risk |
Pathogenic |
Congenital myopathy 4A, autosomal dominant |
| RS2526042624 |
LAMC2
|
Health Risk |
Likely pathogenic |
— |
| RS2526043438 |
LAMC2
|
Health Risk |
Likely pathogenic |
Junctional epidermolysis bullosa gravis of Herlitz, Junctional epidermolysis bullosa gravis of Herlitz |
| RS2526043721 |
LAMC2
|
Health Risk |
Likely pathogenic |
Junctional epidermolysis bullosa gravis of Herlitz, Junctional epidermolysis bullosa gravis of Herlitz |
| RS2526043994 |
ADCY10
|
Health Risk |
Pathogenic |
— |
| RS2526044331 |
LAMC2
|
Health Risk |
Likely pathogenic |
Junctional epidermolysis bullosa gravis of Herlitz, Junctional epidermolysis bullosa gravis of Herlitz |
| RS2526054200 |
LAMC2
|
Health Risk |
Pathogenic |
— |
| RS2526054443 |
LAMC2
|
Health Risk |
Likely pathogenic |
Junctional epidermolysis bullosa gravis of Herlitz, Junctional epidermolysis bullosa gravis of Herlitz |
| RS2526055328 |
TPM3
|
Health Risk |
Likely pathogenic |
Congenital myopathy 4B, autosomal recessive |
| RS2526056353 |
TPM3
|
Health Risk |
Pathogenic/Likely pathogenic |
Congenital myopathy with fiber type disproportion, Congenital myopathy 4B |
| RS2526057284 |
ASH1L
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder, Neurodevelopmental disorder |
| RS2526060163 |
LAMC2
|
Health Risk |
Likely pathogenic |
Junctional epidermolysis bullosa gravis of Herlitz, Junctional epidermolysis bullosa gravis of Herlitz |
| RS2526060515 |
LAMC2
|
Health Risk |
Pathogenic |
— |
| RS2526060814 |
LAMC2
|
Health Risk |
Pathogenic |
— |
| RS2526060945 |
TPM3
|
Health Risk |
Likely pathogenic |
— |
| RS2526064853 |
LAMC2
|
Health Risk |
Likely pathogenic |
Junctional epidermolysis bullosa gravis of Herlitz, Junctional epidermolysis bullosa gravis of Herlitz |
| RS2526065086 |
LAMC2
|
Health Risk |
Likely pathogenic |
Junctional epidermolysis bullosa gravis of Herlitz, Junctional epidermolysis bullosa gravis of Herlitz |
| RS2526068932 |
LAMC2
|
Health Risk |
Likely pathogenic |
Junctional epidermolysis bullosa gravis of Herlitz, Junctional epidermolysis bullosa gravis of Herlitz |
| RS2526069963 |
LAMC2
|
Health Risk |
Pathogenic |
— |
| RS2526082204 |
LAMC2
|
Health Risk |
Likely pathogenic |
Junctional epidermolysis bullosa gravis of Herlitz, Junctional epidermolysis bullosa gravis of Herlitz |
| RS2526082649 |
LAMC2
|
Health Risk |
Likely pathogenic |
Junctional epidermolysis bullosa gravis of Herlitz, Junctional epidermolysis bullosa gravis of Herlitz |
| RS2526082974 |
LAMC2
|
Health Risk |
Pathogenic |
— |
| RS2526088227 |
LAMC2
|
Health Risk |
Pathogenic |
— |
| RS2526088461 |
LAMC2
|
Health Risk |
Likely pathogenic |
Junctional epidermolysis bullosa gravis of Herlitz, Junctional epidermolysis bullosa gravis of Herlitz |
| RS2526088480 |
LAMC2
|
Health Risk |
Likely pathogenic |
Junctional epidermolysis bullosa gravis of Herlitz, Junctional epidermolysis bullosa gravis of Herlitz |
| RS2526088692 |
LAMC2
|
Health Risk |
Pathogenic/Likely pathogenic |
Epidermolysis bullosa, junctional 3A |
| RS2526091818 |
LAMC2
|
Health Risk |
Pathogenic |
— |
| RS2526093353 |
LAMC2
|
Health Risk |
Likely pathogenic |
Junctional epidermolysis bullosa gravis of Herlitz, Junctional epidermolysis bullosa gravis of Herlitz |
| RS2526093455 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2526095429 |
DMD
|
Health Risk |
Likely pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2526095691 |
DMD
|
Health Risk |
Likely pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2526095742 |
DMD
|
Health Risk |
Likely pathogenic |
Duchenne muscular dystrophy, Nonpapillary renal cell carcinoma |
| RS2526100332 |
LAMC2
|
Health Risk |
Pathogenic |
— |
| RS2526103665 |
NOTCH2
|
Health Risk |
Likely pathogenic |
NOTCH2-related disorder, NOTCH2-related disorder |
| RS2526104121 |
NOTCH2
|
Health Risk |
Pathogenic |
— |
| RS2526105965 |
CASQ2
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Catecholaminergic polymorphic ventricular tachycardia 1 |
| RS2526105966 |
NOTCH2
|
Health Risk |
Pathogenic |
Hajdu-Cheney syndrome, Hajdu-Cheney syndrome |
| RS2526106694 |
CASQ2
|
Health Risk |
Pathogenic |
Catecholaminergic polymorphic ventricular tachycardia 1, Catecholaminergic polymorphic ventricular tachycardia 1 |
| RS2526107620 |
NOTCH2
|
Health Risk |
Pathogenic |
Hajdu-Cheney syndrome, Hajdu-Cheney syndrome |
| RS2526107661 |
LAMC2
|
Health Risk |
Pathogenic |
— |
| RS2526107671 |
LAMC2
|
Health Risk |
Likely pathogenic |
Junctional epidermolysis bullosa gravis of Herlitz, Junctional epidermolysis bullosa gravis of Herlitz |
| RS2526107938 |
NOTCH2
|
Health Risk |
Likely pathogenic |
Hajdu-Cheney syndrome, Hajdu-Cheney syndrome |
| RS2526108627 |
LAMC2
|
Health Risk |
Pathogenic |
— |
| RS2526108690 |
LAMC2
|
Health Risk |
Pathogenic |
— |
| RS2526108695 |
NOTCH2
|
Health Risk |
Likely pathogenic |
Alagille syndrome due to a NOTCH2 point mutation, Hajdu-Cheney syndrome |
| RS2526112427 |
TUFT1
|
Health Risk |
Pathogenic |
Woolly hair-skin fragility syndrome, Woolly hair-skin fragility syndrome |
| RS2526112692 |
NOTCH2
|
Health Risk |
Pathogenic |
Hajdu-Cheney syndrome, Hajdu-Cheney syndrome |
| RS2526112731 |
LAMC2
|
Health Risk |
Pathogenic |
— |
| RS2526112802 |
NOTCH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hajdu-Cheney syndrome, Alagille syndrome due to a NOTCH2 point mutation |
| RS2526112913 |
NOTCH2
|
Health Risk |
Pathogenic |
Alagille syndrome due to a NOTCH2 point mutation, Alagille syndrome due to a NOTCH2 point mutation |
| RS2526113347 |
LAMC2
|
Health Risk |
Pathogenic |
— |
| RS2526113458 |
LAMC2
|
Health Risk |
Likely pathogenic |
Junctional epidermolysis bullosa gravis of Herlitz, Junctional epidermolysis bullosa gravis of Herlitz |
| RS2526113536 |
LAMC2
|
Health Risk |
Pathogenic |
— |
| RS2526117083 |
LAMC2
|
Health Risk |
Pathogenic |
— |
| RS2526117177 |
LAMC2
|
Health Risk |
Likely pathogenic |
Junctional epidermolysis bullosa gravis of Herlitz, Junctional epidermolysis bullosa gravis of Herlitz |
| RS2526117873 |
LAMC2
|
Health Risk |
Likely pathogenic |
Junctional epidermolysis bullosa gravis of Herlitz, Junctional epidermolysis bullosa gravis of Herlitz |
| RS2526118497 |
LAMC2
|
Health Risk |
Likely pathogenic |
Junctional epidermolysis bullosa gravis of Herlitz, Junctional epidermolysis bullosa gravis of Herlitz |
| RS2526118589 |
LAMC2
|
Health Risk |
Pathogenic |
— |